The client R&D team was in a race to launch a new immunotherapy within a new indication, which over-indexed in ethnic populations. They didn’t see the volume of patients needed for their phase 2 trial, and recruiting was languishing.
CHM recognized that these patients wanted to be treated by their community oncologist and were not open to transitioning their care to an academic institution. Our team crafted a refined community-based trial recruitment strategy.
The client doubled enrollment — fulfilling trial patient requirements within 8 months and ahead of schedule.
Explore how authentic community engagement can drive results
401 E Jackson St
Tampa, FL 33602
175 Greenwich St
Three World Trade Center
New York, NY 10007